Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRSOTSE:5619 +0.12%41 Net Current Asset Value is 円467.69 as of Jun. 2026. GuruFocus rates TSE:5619 with a GF Score™ of 41/100 and a GF Value™ of 円666.50 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 276 Healthcare Providers & Services companies, MRSO ranks better than 80.07% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
MRSO's net current asset value per share for the quarter that ended in Jun. 2026 was 円467.69.
The historical rank and industry rank for MRSO's Net Current Asset Value or its related term are showing as below:
TSE:5619'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.73 Med: 1.99 Max: 4
Current: 1.83
During the past 5 years, the highest Price-to-Net-Current-Asset-Value Ratio of MRSO was 4.00. The lowest was 1.73. And the median was 1.99.
TSE:5619's Price-to-Net-Current-Asset-Value is ranked better than 80.07% of 276
companies
in the Healthcare Providers & Services industry
Industry Median: 6.315
vs TSE:5619: 1.83
MRSO (TSE:5619) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
MRSO Net Current Asset Value Related Terms
MRSO Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for MRSO's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:5619 vs VEEV, BTSG, TEM: Net Current Asset Value Comparison
For the Health Information Services subindustry, MRSO's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRSO Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRSO's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where MRSO's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of 円467.69 mean?
MRSO (TSE:5619) has a Net Current Asset Value of 円467.69 as of Jun. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MRSO and its competitors. According to the industry distribution chart, MRSO ranks #55 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 19.9%.
Is MRSO's Net Current Asset Value too high?
MRSO's current Net Current Asset Value is 円467.69. Based on the distribution chart, MRSO ranks #55 out of 276 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MRSO has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MRSO's Net Current Asset Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MRSO ranks #55 out of 276 companies for Net Current Asset Value. This places MRSO in the top 20% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 6.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 6.32, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MRSO and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 6.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRSO's current Net Current Asset Value is 円467.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRSO stock overvalued right now?
Based on GuruFocus' analysis, MRSO (TSE:5619) is currently considered Modestly Overvalued. The stock's GF Value™ is 円666.50, compared to a current price of 円854.00 — trading 28.1% above its estimated fair value. The current Net Current Asset Value is 円467.69. MRSO's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For MRSO (TSE:5619), the current Net Current Asset Value is 円467.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRSO (TSE:5619) Overvalued in 2026?
Based on GuruFocus' analysis, MRSO stock appears to be overvalued.
The current stock price of 円854.00 is trading 28.1% above its estimated GF Value™ of 円666.50.
GuruFocus considers MRSO to be Modestly Overvalued.
Key valuation signals for TSE:5619:
Net Current Asset Value: 円467.69
GF Value™: 円666.50 vs. price of 円854.00 (28.1% above fair value)
No single metric tells the full story. See the TSE:5619 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
41GF Score
Get the complete analysis for TSE:5619
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5619 has been successfully added to your 
